methotrexate has been researched along with Abnormality, Heart in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeCampli, W; Piggott, KD; Riddle, E; Sorbello, A | 1 |
| Gui, YH; Jiang, Q; Song, HY; Sun, SN; Wang, YX; Zhong, T | 1 |
| Abbattista, AD; Catena, G; Di Donato, R; La Vigna, G; Parisi, F; Squitieri, C; Vinciguerra, G | 1 |
| Blakemore, KJ; Duhl, AJ; Escallon, CS; Nguyen, C | 1 |
4 other study(ies) available for methotrexate and Abnormality, Heart
| Article | Year |
|---|---|
Congenital cardiac defects: a possible association of aminopterin syndrome and in utero methotrexate exposure?
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Angiography; Cardiac Surgical Procedures; Craniofacial Abnormalities; Diagnosis, Differential; Echocardiography; Female; Follow-Up Studies; Heart Defects, Congenital; Humans; Infant; Intellectual Disability; Lupus Erythematosus, Systemic; Male; Methotrexate; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects | 2011 |
[Folic acid antagonist methotrexate causes the development malformation of heart and down-regulates the BMP2b and HAS2 expressions in zebrafish].
Topics: Abnormalities, Drug-Induced; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Down-Regulation; Folic Acid Antagonists; Gene Expression Regulation; Glucuronosyltransferase; Heart Defects, Congenital; Hyaluronan Synthases; Methotrexate; Polymerase Chain Reaction; Zebrafish; Zebrafish Proteins | 2007 |
Twelve years of cyclosporine in pediatric heart transplantation: what is the future?
Topics: Adolescent; Azathioprine; Cardiomyopathies; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Heart Defects, Congenital; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Infant, Newborn; Kidney Failure, Chronic; Kidney Transplantation; Methotrexate; Reoperation; Retrospective Studies; Steroids; Survival Rate; Time Factors | 1998 |
Multiple anomalies in a fetus exposed to low-dose methotrexate in the first trimester.
Topics: Abnormalities, Multiple; Adolescent; Bone and Bones; Craniofacial Abnormalities; Depression; Digestive System; Digestive System Abnormalities; Female; Fetal Death; Heart Defects, Congenital; Humans; Infant, Newborn; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Psoriasis; Sertraline; Ultrasonography, Prenatal | 2002 |